Botanical species · safety record

Hypericum perforatum

The EFSA Compendium of Botanicals holds 3 constituent measurements, 4 adverse-effect records and 1 genotoxicity assay for Hypericum perforatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hypericum perforatum L.

3Constituent measurements
5Safety records
4Cited sources
546Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 546 licensed products naming Hypericum perforatum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • fluid

Source material stated

  • Aerial part with flowers
  • Aerial parts
  • Aerial parts with flowers
  • Dried aerial part(s)
  • Dried herb tops
  • Flower
  • Flower (standardized extract)
  • Flower and stem

What the records describe

Constituents measured

  • Hyperforin1
  • Hypericin1
  • Pseudohypericin1

Plant parts

  • Live plants1

Preparations

  • Drying (dehydration)1
  • Solvent extraction1

Effect types

  • Other toxicities2
  • Irritation1
  • Neurotoxicity1

Target tissues

  • Skin2
  • subcutis2
  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Hyperforin≥ 2 PercentUnspecifiedResolve DOI
Hypericin0.09 PercentUnspecifiedResolve DOI
Pseudohypericin0.23 PercentUnspecifiedResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
IrritationLive plantsDrying (dehydration)Horse (as animal)Case reportResolve DOI
NeurotoxicityNeurologic: central nervous systemSolvent extractionHuman (as organism)In vitroResolve DOI
Other toxicitiesSkin/subcutisHuman (as organism)Acute toxicityResolve DOI
Other toxicitiesSkin/subcutisHuman (as organism)Acute toxicityResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivechromosome aberrationsubchronicHouse mouse (as animal)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Caloni, F., Cortinovis, C. Plants poisonous to horses in Europe. Equine veterinary education, 2015, vol. 27, no. 5, p. 269-274. DOI
  2. Rietjens, IMCM., Martena, MJ., Boersma, MG., Spiegelenberg, W., Alink, GM. Molecular mechanisms of toxicity of important food-borne phytotoxins. Molecular nutrition & food research, 2005, vol. 49, no. 2, p. 131-158. DOI
  3. Qureshi, Shoeb. Studies on the cytological, biochemical and reproductive toxicity of St. Johna's Wort after chronic treatment in swiss albino mice. American-eurasian journal of toxicological sciences, 2013, vol. 97-103, p. 7.
  4. Jacobson, JM., Feinman, L., Liebes, L., Ostrow, N., Koslowski, V., Tobia, A., Cabana, BE., Lee, DH., Spritzler, J., Prince, AM. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's Wort plant, in patients with chronic hepatitis C virus infection. Antimicrobial agents and chemotherapy, 2001, vol. 45, no. 2, p. 517-524. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue